We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Test for TB Could Eliminate Unnecessary Treatment

By LabMedica International staff writers
Posted on 25 Jun 2014
Print article
T-SPOT TB
Interferon-gamma release assays (IGRA) for the detection of tuberculosis. (Photo courtesy of OXFORD IMMUNOTEC - A Perkin Elmer Company)
A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50% of those screened will not undergo unnecessary treatment due to false positives.

A test for TB using interferon-gamma release assays (IGRA) will detect a preexisting TB infection, or latent TB, that might not present itself for many years, or until the body becomes weakened by another source.

A study group led by infectious disease experts from Queen’s University (Kingston, ON, Canada), tested inmates for TB at a Canadian intake institution before moving on to different corrections facilities. The scientists used both the tuberculosis skin test (TST) for TB which has been used for over 100 years but comes with two main limitations, and the IGRA. The TST requires two visits to determine the results: one to perform the test and then another visit a couple of days later to read the results and depending on the patient's exposure to other mycobacteria or the Bacille Calmette Guerin (BCG) vaccine, accordingly the TST test can give many false positives.

The IGRA tests cannot prove that latent TB infections will progress into active TB until the patient begins to show symptoms. Better tools to predict who will go on to develop active and potentially infectious TB are being actively pursued. The investigators found that 96 inmates tested positive for TB via the TST test, but only 31 of these inmates were confirmed as true latent TB infection when using the IGRA test.

Wendy L.Wobeser, MD, the study’s lead author said, “It is fairly uncommon that latent TB will reactivate, with only about a 10% chance. That said, given the crowding in corrections facilities, the mass exposure of inmates to TB could be disastrous. It is such a slow disease progression that it is hard for us to say with certainty who will actually go on to develop TB. I hope that this test will eventually be used in corrections and is able to reduce people who might otherwise be treated unnecessarily for latent TB.”

Ilan Schwartz, MD, a coauthor of the study said, “What I found surprising was just how much discordance there was between the TST and IGRA tests. Historically, all of those who tested TB-positive by the TST test would have been subjected to 12 months of drug treatments that can have considerable side effects.”

Related Links:

Queen’s University


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Auto-Chemistry Analyzer
CS-1200
New
Nuclear Matrix Protein 22 Test
NMP22 Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.